PlainPill
MedicationAnxiety

Benzo

People mainly take Benzo for anxiety. Based on 3 first-hand reports and 38 meta-analyses & systematic reviews in the medical literature. Ranked #3191 of 4,149 overall.

Compare with…Alternatives for anxiety
6
User score
Mixed
0% positive33% mixed0% negative67% unclear

Of reports that state an outcome, 0% are positive.

Clinical research
AStrong research base
38
meta-analyses
33
RCTs
29,934
papers

What Benzo does, according to users

Of the people who reported each effect, the share who said it got better.

Anxiety100% of 1
betterno changeworse

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found.

Toxicol Ind Health · 2022 · Meta-analysis / systematic review
Tattoo inks are toxicological risks to human health: A systematic review of their ingredients, fate inside skin, toxicity due to polycyclic aromatic hydrocarbons, primary aromatic amines, metals, and overview of regulatory frameworks

Conclusion: The present article addresses the various ingredients of tattoo inks, their metabolic fate inside human skin and unintentionally added impurities that could pose toxicological risk to human health. Public awareness and regulations that are warranted to be implemented globally for improving the safety of tattooing.

PubMed 35592919 ↗
Cochrane Database Syst Rev · 2009 · Meta-analysis / systematic review
Benzodiazepines for delirium

Conclusion: No adequately controlled trials could be found to support the use of benzodiazepines in the treatment of non-alcohol withdrawal related delirium among hospitalised patients, and at this time benzodiazepines cannot be recommended for the control of this condition. Because of the scarcity of trials with randomization of patients, placebo control, and adequate concealment of allocation of subjects, it is clear that further research is required to determine the role of benzodiazepines in the treatment of non-alcohol withdrawal related delirium.

PubMed 19160280 ↗
Cochrane Database Syst Rev · 2009 · Meta-analysis / systematic review
Benzodiazepines for delirium

Conclusion: No adequately controlled trials could be found to support the use of benzodiazepines in the treatment of non-alcohol withdrawal related delirium among hospitalised patients, and at this time benzodiazepines cannot be recommended for the control of this condition. Because of the scarcity of trials with randomization of patients, placebo control, and adequate concealment of allocation of subjects, it is clear that further research is required to determine the role of benzodiazepines in the treatment of non-alcohol withdrawal related delirium.

PubMed 19821364 ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

No doses stated in the reports so far.

Reported side effects

How often each side effect came up across all reports.

No side effects reported so far.

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

No first-hand experiences with a clear outcome yet.
Top discussions (3)

Other options for anxiety

L-Theanine
Supplement · 3,445 reports
54
91% report better anxiety
Mostly positiveAResearch: Strong
Ashwagandha
Supplement · 2,426 reports
49
88% report better anxiety
MixedAResearch: Strong
Phenibut
Substance · 1,020 reports
48
89% report better anxiety
MixedBResearch: Moderate
NAC
Supplement · 2,045 reports
49
90% report better anxiety
MixedAResearch: Strong
Magnesium
Supplement · 2,377 reports
50
90% report better anxiety
Mostly positiveAResearch: Strong
Taurine
Supplement · 1,048 reports
51
93% report better anxiety
Mostly positiveAResearch: Strong

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 3, 2026. How we rate